{"log_id": 18048304662249274, "direction": 0, "words_result_num": 95, "words_result": [{"probability": {"variance": 0.003536, "average": 0.97555, "min": 0.700253}, "location": {"width": 544, "top": 247, "height": 23, "left": 349}, "words": "泌尿生殖器:阴道炎,排尿困难、痛经、血尿、月经过多、夜尿症、多尿症"}, {"probability": {"variance": 0.01382, "average": 0.972126, "min": 0.4465}, "location": {"width": 347, "top": 265, "height": 21, "left": 314}, "words": "尿道感染、肾区痛、白带、子宫出血、阴道出血"}, {"probability": {"variance": 0.000471, "average": 0.990095, "min": 0.908407}, "location": {"width": 379, "top": 284, "height": 20, "left": 349}, "words": "化验改变:在美国进行的Ⅲ期临床试验中,使用推荐"}, {"probability": {"variance": 1e-06, "average": 0.998927, "min": 0.997247}, "location": {"width": 163, "top": 300, "height": 21, "left": 315}, "words": "最常见发生化验参数改"}, {"probability": {"variance": 0.043005, "average": 0.784552, "min": 0.577177}, "location": {"width": 16, "top": 304, "height": 18, "left": 540}, "words": "Al"}, {"probability": {"variance": 0.021176, "average": 0.653164, "min": 0.372367}, "location": {"width": 170, "top": 285, "height": 38, "left": 721}, "words": "sCO关系"}, {"probability": {"variance": 0.002008, "average": 0.982307, "min": 0.841538}, "location": {"width": 157, "top": 321, "height": 19, "left": 321}, "words": "细胞(1,1%)的升高"}, {"probability": {"variance": 0.006303, "average": 0.970215, "min": 0.662436}, "location": {"width": 555, "top": 339, "height": 23, "left": 350}, "words": "上市后不良反应:下列为司帕沙星或其他喹诺酮类药物在世界销售后所报道的"}, {"probability": {"variance": 0.010262, "average": 0.967806, "min": 0.485842}, "location": {"width": 586, "top": 356, "height": 24, "left": 315}, "words": "其他不良反应(不考虑药物关系):酸中毒、急性肾衰,中性粒细胞缺乏症、蛋白"}, {"probability": {"variance": 0.000158, "average": 0.994082, "min": 0.935802}, "location": {"width": 575, "top": 373, "height": 22, "left": 313}, "words": "尿、血管性水肿、嗅觉缺乏症、运动性共济失调、大疱、念珠菌尿、心肺障碍"}, {"probability": {"variance": 0.016875, "average": 0.938978, "min": 0.513359}, "location": {"width": 577, "top": 393, "height": 21, "left": 313}, "words": "脑血栓形成、痉孪、结晶尿、味觉障碍、失语症、栓塞、结节性红斑、重症肌无"}, {"probability": {"variance": 0.018097, "average": 0.923148, "min": 0.5193}, "location": {"width": 594, "top": 411, "height": 23, "left": 313}, "words": "加重、胃痛、济血性贫血、肝环死、肝炎、打嗝、色紫过度沉着、间质性肾炎、尚"}, {"probability": {"variance": 0.001246, "average": 0.987347, "min": 0.816742}, "location": {"width": 574, "top": 429, "height": 24, "left": 314}, "words": "质性肺炎、肠穿孔、黄疸、喉或肺水肿、狂躁、麻木、眼球震颤、腔黏膜疼痛"}, {"probability": {"variance": 0.002922, "average": 0.980638, "min": 0.750372}, "location": {"width": 385, "top": 445, "height": 22, "left": 313}, "words": "胰腺炎、恐怖症、凝血时间延长、伪膜性结肠炎、Q"}, {"probability": {"variance": 0.000756, "average": 0.977763, "min": 0.908918}, "location": {"width": 149, "top": 448, "height": 21, "left": 756}, "words": "水肿、肾结石、横纹"}, {"probability": {"variance": 0.004237, "average": 0.965661, "min": 0.769309}, "location": {"width": 174, "top": 466, "height": 18, "left": 312}, "words": "肌溶解,感觉障碍、Ste"}, {"probability": {"variance": 0.03341, "average": 0.872196, "min": 0.438856}, "location": {"width": 329, "top": 467, "height": 24, "left": 572}, "words": "0症状、磷状细胞癌、腱断裂、颤动、血小"}, {"probability": {"variance": 0.010782, "average": 0.965473, "min": 0.406703}, "location": {"width": 577, "top": 483, "height": 24, "left": 312}, "words": "减少症、血小板减少性紫癜、中毒性表皮坏死松解症、精神病、尿滞留,色素"}, {"probability": {"variance": 3.1e-05, "average": 0.995384, "min": 0.983095}, "location": {"width": 131, "top": 503, "height": 18, "left": 347}, "words": "念珠菌病、脉管炎"}, {"probability": {"variance": 0.011989, "average": 0.963038, "min": 0.528717}, "location": {"width": 297, "top": 514, "height": 31, "left": 347}, "words": "化验变化:高血浆甘油三酸酯、血浆胆"}, {"probability": {"variance": 0.011484, "average": 0.95154, "min": 0.632453}, "location": {"width": 162, "top": 521, "height": 21, "left": 742}, "words": "血钾、降低白细胞、组"}, {"probability": {"variance": 0.013627, "average": 0.947634, "min": 0.584175}, "location": {"width": 313, "top": 538, "height": 22, "left": 313}, "words": "细胞、血色素、血细胞比容及血小板,升窩"}, {"probability": {"variance": 0.006523, "average": 0.944809, "min": 0.784713}, "location": {"width": 175, "top": 522, "height": 41, "left": 634}, "words": " OT, GPT, ALP LDH"}, {"probability": {"variance": 0.027082, "average": 0.822956, "min": 0.600884}, "location": {"width": 36, "top": 542, "height": 18, "left": 869}, "words": "TP及"}, {"probability": {"variance": 0.012389, "average": 0.932185, "min": 0.739487}, "location": {"width": 66, "top": 557, "height": 18, "left": 313}, "words": "总胆红素"}, {"probability": {"variance": 0, "average": 0.999156, "min": 0.998716}, "location": {"width": 78, "top": 573, "height": 22, "left": 312}, "words": "禁忌"}, {"probability": {"variance": 0.008075, "average": 0.974555, "min": 0.585086}, "location": {"width": 321, "top": 592, "height": 26, "left": 362}, "words": "有过敏反应或光过敏反应病史者禁用司帕沙星"}, {"probability": {"variance": 0.027306, "average": 0.915443, "min": 0.4548}, "location": {"width": 542, "top": 609, "height": 32, "left": 361}, "words": "本品禁与丙吡胺、胺碘酮等延长QTc的抗心率失常药物如I3类抗心率失常药"}, {"probability": {"variance": 0.032164, "average": 0.906785, "min": 0.548186}, "location": {"width": 87, "top": 627, "height": 20, "left": 308}, "words": "物(如奎尼"}, {"probability": {"variance": 0.015701, "average": 0.930206, "min": 0.679739}, "location": {"width": 77, "top": 629, "height": 19, "left": 431}, "words": "普鲁卡因胺"}, {"probability": {"variance": 0.009689, "average": 0.938327, "min": 0.651258}, "location": {"width": 357, "top": 629, "height": 21, "left": 547}, "words": "Ⅲ类抗心率失常药物(索他洛尔和苄普地尔)合"}, {"probability": {"variance": 0.016349, "average": 0.93783, "min": 0.516866}, "location": {"width": 594, "top": 644, "height": 28, "left": 308}, "words": "用。已知QTc延长的病人或合用会导致QTc延长和/或 torsade de pointes药物(特非"}, {"probability": {"variance": 0.010807, "average": 0.967453, "min": 0.519855}, "location": {"width": 578, "top": 663, "height": 24, "left": 309}, "words": "那定)治疗的病人禁用司帕沙星,治疗期间及治疗停止5天内避免暴露于阳光,明"}, {"probability": {"variance": 2e-05, "average": 0.996708, "min": 0.983255}, "location": {"width": 228, "top": 684, "height": 19, "left": 309}, "words": "自然光和紫外光下是非常必要的"}, {"probability": {"variance": 0.002168, "average": 0.985066, "min": 0.769854}, "location": {"width": 404, "top": 699, "height": 26, "left": 341}, "words": "3.生活方式或职业中无法避免光毒性的病人禁用司帕沙星"}, {"probability": {"variance": 0.042046, "average": 0.881432, "min": 0.526275}, "location": {"width": 63, "top": 721, "height": 17, "left": 320}, "words": "注意事项"}, {"probability": {"variance": 0.015673, "average": 0.955447, "min": 0.464819}, "location": {"width": 518, "top": 739, "height": 20, "left": 361}, "words": "在治疗过程中或治疗后暴露于直接或间接阳光下或人工紫外线(如太阳灯"}, {"probability": {"variance": 0.004488, "average": 0.973704, "min": 0.643096}, "location": {"width": 598, "top": 753, "height": 29, "left": 305}, "words": "的病人已发生过中至垂度光毒性反应。这种反应也发生在过暴露于阴暗或散射光"}, {"probability": {"variance": 0.00057, "average": 0.986794, "min": 0.939052}, "location": {"width": 83, "top": 775, "height": 18, "left": 309}, "words": "中的病人身"}, {"probability": {"variance": 0.000246, "average": 0.990801, "min": 0.931041}, "location": {"width": 454, "top": 773, "height": 22, "left": 446}, "words": "病人第一次出现光毒性反应症状时,如皮肤灼烧感、发红、发"}, {"probability": {"variance": 5.5e-05, "average": 0.996424, "min": 0.966929}, "location": {"width": 349, "top": 792, "height": 22, "left": 307}, "words": "胀、水泡、皮疹、发痒或皮炎,应停用司帕沙"}, {"probability": {"variance": 0.004783, "average": 0.964745, "min": 0.684811}, "location": {"width": 544, "top": 810, "height": 25, "left": 356}, "words": "在使用司帕沙星治疗过程中和治疗停止5天内,避免直接或间接暴露于阳光(包"}, {"probability": {"variance": 0.003013, "average": 0.978776, "min": 0.794708}, "location": {"width": 324, "top": 831, "height": 19, "left": 329}, "words": "过玻璃,使用了遮光剂或防晒霜,反射光和阴"}, {"probability": {"variance": 5.3e-05, "average": 0.994509, "min": 0.973469}, "location": {"width": 173, "top": 832, "height": 19, "left": 686}, "words": "和人工紫外光(如太阳灯)"}, {"probability": {"variance": 0.001454, "average": 0.98585, "min": 0.813169}, "location": {"width": 485, "top": 847, "height": 23, "left": 308}, "words": "如果无法避免短暂的暴露于阳光下,要用衣服尽量多的遮盖病人的皮肤"}, {"probability": {"variance": 0.013283, "average": 0.7082, "min": 0.578896}, "location": {"width": 102, "top": 828, "height": 34, "left": 903}, "words": " BNG)PHAAUA"}, {"probability": {"variance": 0.005806, "average": 0.982305, "min": 0.59429}, "location": {"width": 445, "top": 866, "height": 21, "left": 356}, "words": "对已经出现司帕沙星光毒性反应的病人要避免再次暴露于阳光"}, {"probability": {"variance": 0.00594, "average": 0.957103, "min": 0.751742}, "location": {"width": 166, "top": 882, "height": 21, "left": 307}, "words": "直到光毒性反应问题已"}, {"probability": {"variance": 0.008609, "average": 0.966779, "min": 0.627809}, "location": {"width": 239, "top": 885, "height": 19, "left": 490}, "words": "解决或病人的光毒性反应已完全康"}, {"probability": {"variance": 0.006149, "average": 0.972864, "min": 0.705513}, "location": {"width": 404, "top": 903, "height": 19, "left": 306}, "words": "在极少数病例中,停止司帕沙星治疗几周后反应可再复发"}, {"probability": {"variance": 0.04385, "average": 0.886167, "min": 0.355979}, "location": {"width": 327, "top": 867, "height": 52, "left": 729}, "words": "复或5天后长时间山东"}, {"probability": {"variance": 0.012977, "average": 0.948198, "min": 0.528554}, "location": {"width": 547, "top": 918, "height": 26, "left": 339}, "words": "4.有报道,使用喹诺酮类药物(包括司帕沙星)的病人可能出现挛和严重"}, {"probability": {"variance": 0.006409, "average": 0.965619, "min": 0.593764}, "location": {"width": 494, "top": 937, "height": 25, "left": 305}, "words": "神病。诺酮也会引起颅内压升高和刺激中枢神经系统、进而导致"}, {"probability": {"variance": 0.021082, "average": 0.914119, "min": 0.592978}, "location": {"width": 149, "top": 910, "height": 42, "left": 906}, "words": "药有限公司S"}, {"probability": {"variance": 0.006425, "average": 0.958529, "min": 0.578846}, "location": {"width": 598, "top": 951, "height": 32, "left": 303}, "words": "奋、忧虑、紧张、轻、意识模糊、幻觉、妾想、消沉、失眠、极少数出现杀惑"}, {"probability": {"variance": 0.009719, "average": 0.976642, "min": 0.422371}, "location": {"width": 545, "top": 973, "height": 24, "left": 305}, "words": "识或行为。这些反应可能在首次给药时发生。因此服用帕沙星的病人出现"}, {"probability": {"variance": 0.003813, "average": 0.980706, "min": 0.633078}, "location": {"width": 599, "top": 990, "height": 28, "left": 301}, "words": "状要停止用药并采取适当的措施。和其他喹诺酮药物一样,对已知或怀疑有可能导"}, {"probability": {"variance": 0.034401, "average": 0.613965, "min": 0.428489}, "location": {"width": 159, "top": 942, "height": 67, "left": 882}, "words": "症"}, {"probability": {"variance": 0.009532, "average": 0.969303, "min": 0.448128}, "location": {"width": 594, "top": 1013, "height": 21, "left": 303}, "words": "致发作或发作阔的降低(如严重的脑动脉硬化,癫痫)的中枢神经系统紊乱疾病的"}, {"probability": {"variance": 0.006211, "average": 0.982172, "min": 0.524755}, "location": {"width": 593, "top": 1027, "height": 26, "left": 305}, "words": "病人或存在其他引起发作或发作网降低(如一定的药物治疗,肾功能紊乱)危险因"}, {"probability": {"variance": 0.020125, "average": 0.906349, "min": 0.557309}, "location": {"width": 215, "top": 1050, "height": 21, "left": 305}, "words": "素的病人要慎重使用司帕沙星"}, {"probability": {"variance": 0.002625, "average": 0.981784, "min": 0.723043}, "location": {"width": 543, "top": 1068, "height": 21, "left": 354}, "words": "有报道服用喹诺酮类药物的病人首次服用后可出现严重的偶然致命性超敏反"}, {"probability": {"variance": 4.3e-05, "average": 0.997008, "min": 0.976211}, "location": {"width": 199, "top": 1086, "height": 20, "left": 335}, "words": "包括过敏性样的或过敏性的"}, {"probability": {"variance": 0.018024, "average": 0.945468, "min": 0.405257}, "location": {"width": 300, "top": 1088, "height": 20, "left": 594}, "words": "反应伴随着血管松弛、低血压/休克、癫"}, {"probability": {"variance": 0.012742, "average": 0.953867, "min": 0.534862}, "location": {"width": 578, "top": 1095, "height": 34, "left": 320}, "words": "作、知觉丧失、麻刺感、血管性水肿(包括舌、喉、嗓和面部水肿)阻"}, {"probability": {"variance": 0.023748, "average": 0.946369, "min": 0.366245}, "location": {"width": 562, "top": 1119, "height": 28, "left": 319}, "words": "包括支气管痉、短和急性呼吸窘迫)、呼吸困难、风疹和/或发痒。因此发"}, {"probability": {"variance": 0.00031, "average": 0.989962, "min": 0.938717}, "location": {"width": 345, "top": 1140, "height": 24, "left": 317}, "words": "帕沙星过敏反应,要即停药,并给予对症治疗"}, {"probability": {"variance": 0.014146, "average": 0.961475, "min": 0.376281}, "location": {"width": 485, "top": 1152, "height": 38, "left": 333}, "words": "6据少数报道,接受喹诺酮治疗的病人出现重致命的不良反"}, {"probability": {"variance": 2e-06, "average": 0.998345, "min": 0.996954}, "location": {"width": 30, "top": 1161, "height": 19, "left": 865}, "words": "些是"}, {"probability": {"variance": 0.007391, "average": 0.972948, "min": 0.596039}, "location": {"width": 596, "top": 1173, "height": 26, "left": 301}, "words": "因为过敏反应,一些则不明病因。这些不良反应可能比较严重,通常发生在多剂"}, {"probability": {"variance": 0.00011, "average": 0.989742, "min": 0.970845}, "location": {"width": 144, "top": 1195, "height": 20, "left": 306}, "words": "用药。临床表现为以"}, {"probability": {"variance": 0.001689, "average": 0.986517, "min": 0.788192}, "location": {"width": 411, "top": 1196, "height": 20, "left": 486}, "words": "种或多种症状:发热、皮疮或严重的皮肤病(如毒性皮肤"}, {"probability": {"variance": 8.6e-05, "average": 0.992605, "min": 0.974542}, "location": {"width": 95, "top": 1211, "height": 21, "left": 307}, "words": "不死溶解,St"}, {"probability": {"variance": 0.023955, "average": 0.919969, "min": 0.416214}, "location": {"width": 442, "top": 1211, "height": 22, "left": 455}, "words": " also综合症)脉管炎;关节痛;肌痛;血清疾病;过敏性"}, {"probability": {"variance": 0.013603, "average": 0.943904, "min": 0.547316}, "location": {"width": 599, "top": 1229, "height": 26, "left": 299}, "words": "肺炎;间质性肾炎;急性肾损伤或衰竭;肝炎;黄疸:急性肝坏死或衰竭:贫血(包"}, {"probability": {"variance": 0.011036, "average": 0.958952, "min": 0.492866}, "location": {"width": 595, "top": 1247, "height": 22, "left": 300}, "words": "括溶血性和再生障碍性):血小板减少症,包括血栓形成性血小板减少性紫癜;自细胞"}, {"probability": {"variance": 0.007454, "average": 0.968442, "min": 0.580497}, "location": {"width": 596, "top": 1268, "height": 22, "left": 302}, "words": "减少:粒性白血球缺乏症;全血细胞减少症和/或其他溶血异常。首次出现皮疹或其他"}, {"probability": {"variance": 0.000582, "average": 0.988998, "min": 0.877014}, "location": {"width": 393, "top": 1285, "height": 25, "left": 304}, "words": "超敏反应症状时要立即停止用药,并采取适当的治疗措施"}, {"probability": {"variance": 0.016414, "average": 0.943593, "min": 0.464459}, "location": {"width": 580, "top": 1300, "height": 45, "left": 299}, "words": "有轻据报道几乎使用所有的抗生紫都出现伪膜性结肠炎,包括司帕沙星,程"}, {"probability": {"variance": 0.000392, "average": 0.988691, "min": 0.907581}, "location": {"width": 597, "top": 1322, "height": 22, "left": 300}, "words": "有轻度至重度,甚至致命。因此,考虑对服用本品并发腹泻的病人进行诊断是"}, {"probability": {"variance": 0.001335, "average": 0.968358, "min": 0.922244}, "location": {"width": 85, "top": 1342, "height": 20, "left": 302}, "words": "非常重要的"}, {"probability": {"variance": 0.012195, "average": 0.952857, "min": 0.572944}, "location": {"width": 564, "top": 1359, "height": 25, "left": 331}, "words": "8.有报道服用司帕沙星和其他诺酮药物出现需进行手术修复的启、手和跟腿"}, {"probability": {"variance": 0.002673, "average": 0.97745, "min": 0.75239}, "location": {"width": 596, "top": 1377, "height": 26, "left": 297}, "words": "断裂或延长劳动能力丧失的现象。如果病人出现疼痛、发炎或腱断裂要停止使用"}, {"probability": {"variance": 0.016045, "average": 0.936271, "min": 0.465121}, "location": {"width": 594, "top": 1394, "height": 24, "left": 300}, "words": "司帕沙星。休息并通过锻炼恢复,直至经诊断腱炎或断褰已完全排除。腱断"}, {"probability": {"variance": 0.007067, "average": 0.957051, "min": 0.617956}, "location": {"width": 433, "top": 1415, "height": 23, "left": 300}, "words": "裂可能发生在使用司帕沙星治疗过程中和治疗后的任何时刻"}, {"probability": {"variance": 0.00953, "average": 0.958118, "min": 0.474973}, "location": {"width": 539, "top": 1434, "height": 20, "left": 356}, "words": "门帕沙星可能导致神经不良反应(如头昏),因此病人在驾驶汽车、操纵机"}, {"probability": {"variance": 0.000967, "average": 0.988751, "min": 0.82919}, "location": {"width": 502, "top": 1452, "height": 21, "left": 297}, "words": "器、进行其他需要智力的活动或协调前要了解司帕沙星是怎样起作用的"}, {"probability": {"variance": 0.001048, "average": 0.978949, "min": 0.890436}, "location": {"width": 491, "top": 1469, "height": 24, "left": 333}, "words": "10.服用司帕沙星的病人要保证有充分的水合作用,防止形成高浓度尿"}, {"probability": {"variance": 0.006624, "average": 0.942304, "min": 0.761257}, "location": {"width": 266, "top": 1489, "height": 22, "left": 333}, "words": "11.功能异常者慎用或适当降低剂量"}, {"probability": {"variance": 8e-06, "average": 0.99846, "min": 0.990682}, "location": {"width": 177, "top": 1504, "height": 20, "left": 296}, "words": "孕妇及哺乳期妇女用药"}, {"probability": {"variance": 0.005758, "average": 0.967669, "min": 0.623216}, "location": {"width": 558, "top": 1524, "height": 22, "left": 336}, "words": "对怀孕妇女没有充分可控的研究,孕妇禁用。可帕沙星可以进入人体乳汁。因"}, {"probability": {"variance": 0.003488, "average": 0.9834, "min": 0.673607}, "location": {"width": 518, "top": 1538, "height": 26, "left": 293}, "words": "此婴儿通过母乳吸收司帕沙星存在出现严重的不良反应的可能,应用"}, {"probability": {"variance": 0.012836, "average": 0.918149, "min": 0.757937}, "location": {"width": 50, "top": 1545, "height": 19, "left": 842}, "words": "时应停"}, {"probability": {"variance": 0.0001, "average": 0.989949, "min": 0.979972}, "location": {"width": 53, "top": 1561, "height": 18, "left": 294}, "words": "哺乳"}, {"probability": {"variance": 0, "average": 0.98665, "min": 0.98665}, "location": {"width": 38, "top": 1616, "height": 50, "left": 1111}, "words": "∥"}], "language": -1}